Nexosome Oncology

Lexington, United States

Nexosome Oncology focus on the applications of exosome-based diagnostics in the cancer field.

$3.7M raised

Nov 2021

Seed

Health Care Health Diagnostics Oncology

Top Investors

OCA Ventures Keyhorse Capital VisionTech Partners

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nexosome Oncology

How much funding has Nexosome Oncology raised?

Nexosome Oncology has raised $3.7M in total funding. The most recent round was Seed. The last funding was announced in November 2021.

Who are Nexosome Oncology's investors?

Nexosome Oncology's investors include OCA Ventures, Keyhorse Capital, VisionTech Partners.

Where is Nexosome Oncology headquartered?

Nexosome Oncology is headquartered in Lexington, United States.

What does Nexosome Oncology do?

Nexosome Oncology focus on the applications of exosome-based diagnostics in the cancer field.

What stage is Nexosome Oncology at?

Nexosome Oncology is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 22, 2021.

MLA

"Nexosome Oncology — Funding & Investors." VCBacked, November 22, 2021, https://www.vcbacked.co/company/nexosome-oncology. Accessed July 2, 2026.

APA

VCBacked. (2021). Nexosome Oncology — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nexosome-oncology

Wikipedia (cite web)

{{cite web |title=Nexosome Oncology — Funding & Investors |url=https://www.vcbacked.co/company/nexosome-oncology |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 22, 2021.

Similar Companies in Health Care

View all

Oryl Photonics

Lausanne

Allterum Therapeutics